These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 2311984)

  • 1. Hepatic biliary lipid secretion and gall bladder biliary lipid mass in gall stone patients: effect of ursodeoxycholic acid.
    Lanzini A; Northfield TC
    Gut; 1990 Feb; 31(2):226-30. PubMed ID: 2311984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ursodeoxycholic acid on biliary lipid coupling and on cholesterol absorption during fasting and eating in subjects with cholesterol gallstones.
    Lanzini A; Northfield TC
    Gastroenterology; 1988 Aug; 95(2):408-16. PubMed ID: 3391368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gall stone disease without gall stones--bile acid and bile lipid metabolism after complete gall stone dissolution.
    Ruppin DC; Murphy GM; Dowling RH
    Gut; 1986 May; 27(5):559-66. PubMed ID: 3699565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary lipid output during three meals and an overnight fast. I. Relationship to bile acid pool size and cholesterol saturation of bile in gallstone and control subjects.
    Northfield TC; Hofmann AF
    Gut; 1975 Jan; 16(1):1-11. PubMed ID: 806491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid treatment in cholesterol gallstone disease: effects on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, biliary lipid composition, and plasma lipid levels.
    Angelin B; Ewerth S; Einarsson K
    J Lipid Res; 1983 Apr; 24(4):461-8. PubMed ID: 6854153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxycholic acid in gall bladder bile does not account for the shortened nucleation time in patients with cholesterol gall stones.
    Noshiro H; Chijiiwa K; Makino I; Nakano K; Hirota I
    Gut; 1995 Jan; 36(1):121-5. PubMed ID: 7890215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.
    Nilsell K; Angelin B; Leijd B; Einarsson K
    Gastroenterology; 1983 Dec; 85(6):1248-56. PubMed ID: 6628924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose ursodeoxycholic acid prolongs cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones.
    Jüngst D; Brenner G; Pratschke E; Paumgartner G
    J Hepatol; 1989 Jan; 8(1):1-6. PubMed ID: 2921499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biliary lipid metabolism in gallstone disease and during gallstone dissolution treatment.
    Nilsell K
    Acta Chir Scand Suppl; 1985; 528():1-38. PubMed ID: 3866449
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of ursodeoxycholic acid on biliary bile acid and bile lipid composition in gallstone patients.
    Stiehl A; Raedsch R; Rudolph G; Walker S
    Hepatology; 1984; 4(1):107-11. PubMed ID: 6693062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced cholesterol metastability of hepatic bile and its further decline in gall bladder bile in patients with cholesterol gall stones.
    Nakano K; Chijiiwa K
    Gut; 1993 May; 34(5):702-7. PubMed ID: 8504975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodeoxycholic acid therapy and biliary lipids--a dose-response study.
    Bateson MC; Ross PE; Murison J; Saunders JH; Bouchier IA
    Gut; 1980 Apr; 21(4):305-10. PubMed ID: 7429292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ursodeoxycholic acid administration on biliary lipid secretion in primary biliary cirrhosis.
    Roda E; Mazzella G; Bazzoli F; Villanova N; Minutello A; Simoni P; Ronchi M; Poggi C; Festi D; Aldini R
    Dig Dis Sci; 1989 Dec; 34(12 Suppl):52S-58S. PubMed ID: 2598768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.
    von Bergmann K; Epple-Gutsfeld M; Leiss O
    Gastroenterology; 1984 Jul; 87(1):136-43. PubMed ID: 6724256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Effects on biliary lipid metabolism during weight maintenance and weight reduction.
    Mazzella G; Bazzoli F; Festi D; Ronchi M; Aldini R; Roda A; Grigolo B; Simoni P; Villanova N; Roda E
    Gastroenterology; 1991 Aug; 101(2):490-6. PubMed ID: 2065925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of diet on bile acid kinetics and biliary lipid secretion in gallstone patients treated with ursodeoxycholic acid.
    Frenkiel PG; Lee DW; Cohen H; Gilmore CJ; Resser K; Bonorris GG; Marks JW; Schoenfield LJ
    Am J Clin Nutr; 1986 Feb; 43(2):239-50. PubMed ID: 3004189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleation time of gall bladder bile in gall stone patients: influence of bile acid treatment.
    Sahlin S; Ahlberg J; Angelin B; Reihnér E; Einarsson K
    Gut; 1991 Dec; 32(12):1554-7. PubMed ID: 1773966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the effects of an equal dose of 15 mg/kg/day of chenodeoxycholic and ursodeoxycholic acid on the composition of biliary lipids and acids in the bile in radiotransparent biliary lithiasis].
    Garrido G; Breto M; Alegre B; Pérez Aguilar F; Berenguer J
    Rev Esp Enferm Apar Dig; 1983 Oct; 64(4):261-9. PubMed ID: 6658120
    [No Abstract]   [Full Text] [Related]  

  • 20. Is duodenal bile representative of gallbladder bile? A comparative study.
    Choudhuri G; Agarwal DK; Saraswat VA; Negi TS; Saxena R; Kapoor VK
    Scand J Gastroenterol; 1993 Oct; 28(10):920-3. PubMed ID: 8266023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.